Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
PIT565 / Novartis
NCT06335979: An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).	Not yet recruiting	1	54	NA	PIT565	Novartis Pharmaceuticals	Systemic Lupus Erythematosus, SLE	11/27	11/27
NCT05397496: Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies	Recruiting	1	140	Europe, Japan, US, RoW	PIT565	Novartis Pharmaceuticals	B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL)	06/27	06/28